Meinian Onehealth Healthcare Holdings Co., Ltd. (002044.SZ)
CNY 4.92
(-1.2%)
CNY 4.92
(-1.2%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.21 Billion CNY | 2557.18% |
| 2022 | 45.75 Million CNY | -94.5% |
| 2021 | 831.27 Million CNY | -50.52% |
| 2020 | 1.67 Billion CNY | 56.11% |
| 2019 | 1.07 Billion CNY | -17.02% |
| 2018 | 1.29 Billion CNY | 43.48% |
| 2017 | 903.84 Million CNY | 81.88% |
| 2016 | 496.95 Million CNY | 38.94% |
| 2015 | 357.66 Million CNY | 424.24% |
| 2014 | 68.22 Million CNY | 470.15% |
| 2013 | -18.43 Million CNY | -122.59% |
| 2012 | 81.58 Million CNY | 5.01% |
| 2011 | 77.68 Million CNY | 141.24% |
| 2010 | 32.2 Million CNY | 16.69% |
| 2009 | 27.59 Million CNY | 66.69% |
| 2008 | 16.55 Million CNY | -46.26% |
| 2007 | 30.8 Million CNY | -9.46% |
| 2006 | 34.02 Million CNY | 16.85% |
| 2005 | 29.11 Million CNY | 2.98% |
| 2004 | 28.27 Million CNY | -1.62% |
| 2003 | 28.74 Million CNY | 23.87% |
| 2002 | 23.2 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 402.66 Million CNY | 116.35% |
| 2024 Q2 | 186.11 Million CNY | 172.8% |
| 2024 Q1 | -255.66 Million CNY | -144.32% |
| 2023 Q1 | -160.83 Million CNY | -7704.95% |
| 2023 Q4 | 576.87 Million CNY | 88.14% |
| 2023 FY | 1.21 Billion CNY | 2557.18% |
| 2023 Q3 | 306.61 Million CNY | 44.11% |
| 2023 Q2 | 212.76 Million CNY | 232.29% |
| 2022 FY | 45.75 Million CNY | -94.5% |
| 2022 Q1 | -422.01 Million CNY | -183.07% |
| 2022 Q2 | -179.21 Million CNY | 57.53% |
| 2022 Q3 | 414.55 Million CNY | 331.32% |
| 2022 Q4 | 2.11 Million CNY | -99.49% |
| 2021 Q1 | -464.15 Million CNY | -133.55% |
| 2021 FY | 831.27 Million CNY | -50.52% |
| 2021 Q2 | 36.06 Million CNY | 107.77% |
| 2021 Q3 | 311.24 Million CNY | 763.05% |
| 2021 Q4 | 508.02 Million CNY | 63.22% |
| 2020 Q2 | -281.6 Million CNY | 62.57% |
| 2020 Q4 | 1.38 Billion CNY | 188.68% |
| 2020 Q3 | 479.23 Million CNY | 270.18% |
| 2020 FY | 1.67 Billion CNY | 56.11% |
| 2020 Q1 | -752.44 Million CNY | 27.71% |
| 2019 Q2 | 236.36 Million CNY | 250.44% |
| 2019 FY | 1.07 Billion CNY | -17.02% |
| 2019 Q1 | -157.11 Million CNY | -125.03% |
| 2019 Q3 | 512.82 Million CNY | 116.96% |
| 2019 Q4 | -1.04 Billion CNY | -302.97% |
| 2018 Q2 | 437 Million CNY | 468.49% |
| 2018 FY | 1.29 Billion CNY | 43.48% |
| 2018 Q1 | -118.59 Million CNY | -121.16% |
| 2018 Q4 | 627.61 Million CNY | 69.92% |
| 2018 Q3 | 369.37 Million CNY | -15.48% |
| 2017 FY | 903.84 Million CNY | 81.88% |
| 2017 Q1 | -135.36 Million CNY | -139.17% |
| 2017 Q4 | 560.51 Million CNY | 100.65% |
| 2017 Q3 | 279.34 Million CNY | 40.25% |
| 2017 Q2 | 199.17 Million CNY | 247.14% |
| 2016 FY | 496.95 Million CNY | 38.94% |
| 2016 Q1 | -171.85 Million CNY | -165.71% |
| 2016 Q2 | 148.47 Million CNY | 186.4% |
| 2016 Q4 | 345.54 Million CNY | 97.7% |
| 2016 Q3 | 174.78 Million CNY | 17.72% |
| 2015 Q3 | 131.02 Million CNY | 1682.21% |
| 2015 Q1 | 5.68 Million CNY | 380.87% |
| 2015 FY | 357.66 Million CNY | 424.24% |
| 2015 Q2 | 7.35 Million CNY | 29.25% |
| 2015 Q4 | 261.51 Million CNY | 99.6% |
| 2014 Q3 | 54.2 Million CNY | 451.89% |
| 2014 FY | 68.22 Million CNY | 470.15% |
| 2014 Q4 | -2.02 Million CNY | -103.74% |
| 2014 Q2 | 9.82 Million CNY | 57.7% |
| 2014 Q1 | 6.22 Million CNY | 109.05% |
| 2013 Q3 | 37.31 Million CNY | 478.28% |
| 2013 Q4 | -68.82 Million CNY | -284.44% |
| 2013 FY | -18.43 Million CNY | -122.59% |
| 2013 Q1 | 6.62 Million CNY | -78.69% |
| 2013 Q2 | 6.45 Million CNY | -2.56% |
| 2012 Q2 | 6.07 Million CNY | -16.8% |
| 2012 FY | 81.58 Million CNY | 5.01% |
| 2012 Q4 | 31.08 Million CNY | -16.26% |
| 2012 Q3 | 37.11 Million CNY | 510.51% |
| 2012 Q1 | 7.3 Million CNY | -79.22% |
| 2011 Q2 | 4.5 Million CNY | -26.67% |
| 2011 FY | 77.68 Million CNY | 141.24% |
| 2011 Q4 | 35.15 Million CNY | 10.26% |
| 2011 Q3 | 31.88 Million CNY | 608.26% |
| 2011 Q1 | 6.13 Million CNY | -38.69% |
| 2010 FY | 32.2 Million CNY | 16.69% |
| 2010 Q2 | 2.41 Million CNY | -51.58% |
| 2010 Q3 | 14.79 Million CNY | 513.43% |
| 2010 Q1 | 4.98 Million CNY | -50.97% |
| 2010 Q4 | 10.01 Million CNY | -32.32% |
| 2009 Q4 | 10.16 Million CNY | -11.89% |
| 2009 Q2 | 1.7 Million CNY | -59.29% |
| 2009 Q3 | 11.53 Million CNY | 574.92% |
| 2009 FY | 27.59 Million CNY | 66.69% |
| 2009 Q1 | 4.19 Million CNY | 269.42% |
| 2008 Q4 | 1.13 Million CNY | -88.91% |
| 2008 Q2 | 1.82 Million CNY | -45.59% |
| 2008 FY | 16.55 Million CNY | -46.26% |
| 2008 Q3 | 10.24 Million CNY | 461.08% |
| 2008 Q1 | 3.35 Million CNY | -32.09% |
| 2007 FY | 30.8 Million CNY | -9.46% |
| 2007 Q2 | 2.71 Million CNY | -49.99% |
| 2007 Q3 | 17.71 Million CNY | 551.39% |
| 2007 Q4 | 4.93 Million CNY | -72.11% |
| 2007 Q1 | 5.43 Million CNY | -16.54% |
| 2006 Q3 | 18.78 Million CNY | 345.45% |
| 2006 FY | 34.02 Million CNY | 16.85% |
| 2006 Q4 | 6.51 Million CNY | -65.32% |
| 2006 Q1 | 4.51 Million CNY | -45.79% |
| 2006 Q2 | 4.21 Million CNY | -6.55% |
| 2005 Q4 | 8.32 Million CNY | -48.39% |
| 2005 Q2 | 1.56 Million CNY | -49.41% |
| 2005 Q1 | 3.09 Million CNY | -68.65% |
| 2005 Q3 | 16.12 Million CNY | 928.71% |
| 2005 FY | 29.11 Million CNY | 2.98% |
| 2004 Q3 | 14.31 Million CNY | 0.0% |
| 2004 Q4 | 9.88 Million CNY | -30.96% |
| 2004 FY | 28.27 Million CNY | -1.62% |
| 2003 FY | 28.74 Million CNY | 23.87% |
| 2002 FY | 23.2 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| C.Q. Pharmaceutical Holding Co., Ltd. | 1 Billion CNY | -20.733% |
| Aier Eye Hospital Group Co., Ltd. | 4.94 Billion CNY | 75.426% |